J Yu, A Zhuang, X Gu, Y Hua, L Yang,
S Ge, J Ruan… - Cell Discovery, 2023 - nature.com
Targeting programmed cell death protein ligand 1 (PD-L1) remains one of the most essential
immunotherapies in cancer,. PD-L1 has been detected in the nucleus in multiple …